Background The evaluation of health technologies plays a crucial role in the allocation of
resources and the promotion of equitable healthcare access, known as health technology …

Background WHO reported that 5.5 million people died in the world because of COVID-19.
One of the efforts to mitigate the pandemic is administrating the vaccines globally. Objective …

The available evidence on relative effectiveness and risks of new health technologies is
often limited at the time of health technology assessment (HTA). Additionally, a wide variety …

Ideally, all health policy decisions should involve the use of HTA processes and methods
which offer quality, context-specific and locally relevant evidence. However, where the 'gold …

Even though randomized controlled clinical trials (RCTs) have been accepted as the gold
standard for official assessment of novel interventions, there is a substantial gap between …

Background The use of real-world data (RWD) warehouses for research in Asia is on the
rise, but current trends remain largely unexplored. Given the varied economic and health …

Tackling cancer is a major challenge right on the global level. Europe is only the tip of an
iceberg of cancer around the world. Prosperous developed countries share the same …

Real-world evidence (RWE) is being increasingly used by a wide range of stakeholders
involved in the therapeutic product lifecycle but remains underutilized in the health …

Objective: This review aimed to assess the current use and acceptance of real-world data
(RWD) and real-world evidence (RWE) in health technology assessment (HTA) process. It …

Objective To provide recommendations for overcoming the challenges associated with the
generation and use of real-world evidence (RWE) in regulatory approvals, health technology …